{"version":"1.0","provider_name":"MakingPharmaIndustry","provider_url":"https:\/\/makingpharmaindustry.it\/en\/","author_name":"Valentina Parrella","author_url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/","title":"Validation of DTx - MakingPharmaIndustry","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"SstR1LHPnm\"><a href=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/validation-of-dtx\/\">Validation of DTx<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/validation-of-dtx\/embed\/#?secret=SstR1LHPnm\" width=\"600\" height=\"338\" title=\"&#8220;Validation of DTx&#8221; &#8212; MakingPharmaIndustry\" data-secret=\"SstR1LHPnm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/makingpharmaindustry.it\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/07\/AdobeStock_850441653-scaled.jpeg","thumbnail_width":2560,"thumbnail_height":1435,"description":"In the debate on methods of clinical validation of DTx, one possible approach is to consider software as the 'active ingredient' and the user interface as the 'excipient' to be adapted to the socio-cultural context of patients."}